Introduction appreciable adverse effects in transgenic animals expressThe basic principle of gene-based therapies is efficient ing the TRS. [13] [14] [15] [16] The TRS is founded on the efficiency of delivery of therapeutic genes to mammalian cells and Tc resistance operon of E. coli 17 and the general functheir adequate expression. Advances in the field of gene tionality of the herpes simplex virus transactivator therapy have mainly focused on the development and (VP16) 18 in eukaryotic cells. employment of viral and nonviral systems for delivery
The TRS has obvious applications in gene therapy of foreign genes into target cells. However, recent work where the level and timing of gene expresssion can be has shown that a specific dose of the therapeutic gene modified to meet specific therapeutic regimens. Howproduct is required for successful treatment of certain ever, for this purpose, the original system is not ideal as it diseases 1,2 and excessive production of the gene product requires the co-delivery of a plasmid containing the tTA may be toxic.
3,4 Thus, a regulatable system that can offer expression cassette and another containing a foreign gene tight control of gene expression in response to inducible under the control of tRP to the same cells. Nevertheless, agents that can be safely administered is of value for this approach has demonstrated two orders of magnitude modifying specific therapies. Although a variety of reguof gene regulation on co-injection of plasmids into rat latable promoters have been described, most suffer from heart 19 and into mouse muscle, 20 and on co-infection of high promoter leakiness, poor regulation of gene cells with two recombinant adenoviruses. 21 Although, for expression and employment of inducible agents that are efficient in vivo gene delivery a single construct is associated with adverse effects to mammalian cells. [5] [6] [7] [8] [9] [10] clearly preferable. The tetracycline-regulatable system (TRS) 11 avoids the Our initial studies of a single plasmid, containing the problems related to many of the other systems by offertwo essential elements of the TRS (pSiaII), showed siging substantial regulation of transgene expression in nificant expression of mGM-CSF in the absence of Tc and response to concentrations of tetracycline (Tc) that can be a time-dependent reduction of mGM-CSF level in the repetitively administered. Indeed, the low cytotoxicity of presence of Tc. The maximal degree of repression of Tc and its high affinity for the tetR, 10 gle Tc-controlled constructs [22] [23] [24] [25] [26] [27] that show modest regumGM-CSF and pCMV* mGM-CSF/mIL-2 were comparable single Tc-regulatable vectors in transient transfection with those of the corresponding parental controls and assays. We describe a positive feedback regulatory vector therefore with one another. This indicates that the biwith high maximal expression and low Tc-repressed directional promoter is quantitatively regulated by tTA basal expression. This vector was characterised in several in a direction-independent manner. We also obtained different cell lines to establish its general application. The comparable repression for luciferase indicating that our superior efficiency of the system in regulating gene studies with mIL-2 and mGM-CSF can be compared with expression in a nonintegrated form was shown to apply those of other investigators using luciferase as a reporter to the integrated form of the vector. Thus, we demongene (data not shown). strate a novel PFRS that displays substantial expression and tight regulation of a transgene.
Construction of a tetracycline-controlled, positive feedback regulatory system
Results
Having established that the constructed promoter is bidirectionally regulated by tTA, the capability of the proCharacterisation of a bidirectional promoter based on moter to positively up-regulate itself was tested using the tTA-responsive element pCMV* −1
tTA/mGM-CSF. This plasmid is identical to In order to improve the degree of regulation from a selfpCMV*
mGM-CSF/mIL-2 apart from having the tTA contained plasmid, we aimed at reducing the basal sequence replacing mIL-2 cDNA. In theory, both tTA and expression of the system without compromising its high mGM-CSF will be produced at basal levels on transfeclevel of expression by employing an enhancerless bidirection of eukaryotic cells. The tTA will interact with its protional promoter. 28 The degrees of expression and regumoter, increasing the expression of its own gene and lation of mIL-2 and mGM-CSF from the bidirectional promGM-CSF. This will result in increased concentration of moter of pCMV* −1 mGM-CSF/mIL-2 ( Figure 1) were tTA which will perpetually continue to up-regulate its quantitatively compared with their parental controls in a promoter bidirectionally. The system should therefore tTA-expressing 293 cell line (293-pCEP.tTA). The behave as a positive feedback mechanism and should detected level of mIL-2 ( Figure 2 ) is approximately twice also offer increased sensitivity to Tc repression (discussed that of mGM-CSF. This is not only seen with pCMV* 
mGM-CSF -Tc ( ) and + Tc (ᮀ).
on a similar basis to the autoregulatory inducible pCMV* −1 tTA/mGM-CSF was reconstructed in stages to make pSiaIV (Figure 1 ). This vector contains the vectors. 29, 30 To characterise pCMV* −1 tTA/mGM-CSF, HeLa cells upstream region of CMV IE promoter including the CCAAT and TATA boxes. It also contains the chimeric were transfected with pSiaII, pCMV* mGM-CSF, about 201-fold. Thus, modifications of the tTA-half of the bidirectional concentration of tTA, expression and therefore regulation of the system should be enhanced. This can be achieved promoter designed to increase expression of tTA led to enhanced gene regulation, without compromising the either by increasing tTA expression selectively or lengthening the duration of its expression.
basal expression of mGM-CSF.
Applicability of the positive feedback regulatory system Selective modifications of the tTA-half of the bidirectional promoter in other cell lines The plasmid pSiaIV was tested and compared with To increase the expression of mGM-CSF from the bidirectional promoter and therefore to enhance the degree of pSiaII, pCMV* −1 mGM-CSF and pCMVmGM-CSF in several commonly used cell lines, including HeLa, A431, 293 regulation, we attempted modifications aimed at increasing tTA expression without compromising the basal and NIH3T3. The results at the time of maximal expression of pCMVmGM-CSF, pSiaII and pSiaIV are expression of mGM-CSF expression. To that end, the 
mGM-CSF ( ).
concentrations of mGM-CSF. Stable cells expressing pSiaII and pSiaIV were established and grown in the presence of 1 g/ml of doxycycline (Dox) for several shown in Figure 5 . In most of the lines tested, mGM-CSF expression from pSiaII, pSiaIV and pCMVmGM-CSF weeks. Dox was used instead of Tc since this analogue is more effective in inactivating tTA and maintains were relatively comparable and within a two-fold difference. At 60 h, depending on the cell lines used, the repression of tRP for a longer period following initial treatment. 32 Despite several attempts, we failed to estabdegree of regulation achieved with pSiaIV was from sixto 40-fold better than that seen with pSiaII. The difference lish stable 293 cells with pSiaIV. With this cell line, growing clones died following Dox removal from the culture in the levels of regulation of the two plasmids is dictated by the difference in the basal activity of the Tc-repressed medium. This may be a result of tTA cytotoxicity, 33, 34 since the activity of the positive feedback regulator vectRPs. Whereas activity of the Tc-repressed tRP of pSiaIV reaches that of the leakiness of pCMV *−1 mGM-CSF in all tors are remarkably high in this cell type. Shockett et al 30 have also observed greater than 50% cell death, upon the the cells tested, that of pSiaII remains at a significantly higher level.
removal of Tc from the culture medium, in NIH3T3 clones transfected stably with a plasmid transcribing tTA Finally, consistent with the observations of AcklandBerglund and Leib, 31 we confirm that the degree of leakunder the control of tRP.
As seen in transient studies, the degree of transgene iness varies in different cell lines and is dependent on other cellular factors characteristic of a particular cell regulation with pSiaIV was again superior to that of pSiaII (Table 1) . Thus pSiaIV offers a convenient type.
approach for generating stable cells with a significant degree of transgene regulation. The results reported Comparison of pSiaII and pSiaIV in stable forms To explore the potential use of the PFRS in stably transabove show the degree of regulation in a pool of cells. In selected clones, a higher degree of control may be fected cells, the efficiency of pSiaIV in regulating transgene expression was compared with that of pSiaII in inteexpected. pSiaII showed a low degree of gene regulation Cells transfected with pSiaIV died upon the removal of Dox from the medium. Cells were grown in the absence of Tcs for 15 days and then seeded as a pool of 2 × 10 5 cells per well of six-well plates in culture medium with or without 1 g/ml of Tc. The medium was replaced with fresh culture medium with or without 1 g/ml of Tc at 80 h. Samples of the supernatants were taken at 100 h following seeding. Mean shows the average of mGM-CSF level for five wells in duplicate and s.e. indicates the standard error of the mean.
mGM-CSF or pCMVmGM-CSF per well. Also, 0.2 pmoles of pCH110 per well was included in all the transfection mixtures. Cells were treated as described in Figure 3. Each value represents the mean of five samples in duplicate at 60 h and the bar indicates the standard error of the mean. Numbers of cells expressing ␤-galactosidase were within 1.0-to 1.34-fold of each other between the wells. pCMVmGM-CSF ( ), pSiaII -Tc ( ) and + Tc ( ), pSiaIV -Tc ( ) and + Tc (), pCMV* −1 mGM-CSF (ᮀ).
in most cells apart from 293 where it produced over 150-been shown to be more efficient than Tc, 26, 32 anhydrofold of control.
tetracycline, minocycline and oxytetracycline in inactivating tTA. 32 At 60 h, the PFRS was completely repressed Characterisation of the positive feedback regulatory at Dox concentration range of 1000 ng/ml to 10 ng/ml, system in response to different concentrations of with minimal expression at 1 ng/ml. Partial expression doxycycline from the system occurred in the range of 1 ng/ml to To establish the sensitivity of the PFRS, the effect of dif-0.0 ng/ml of Dox ( Figure 6 ). ferent Dox doses was studied on AM12-pSiaIV. Dox has increase the expression of tTA without compromising the basal activity of the promoter. We show that a modified bidirectional vector, pSiaIV, containing the CCAAT and TATA boxes, a chimeric intron and a modified translational initiation sequence exhibited over 200-fold regulation in HeLa cells after 60 h of treatment with 1 g/ml of Tc. This plasmid also demonstrated superior regulation relative to pSiaII in Vero, NIH3T3, 293 and A431 cells. Moreover, the expression level of pSiaIV is comparable within two-fold to that of the intact CMV IE promoter and pSiaII in most of the cells studied. In all the cell lines tested, the activity of the Tc-repressed pSiaIV is comparable to the basal expression of pCMV* −1 mGM-CSF. Since the expression from pSiaIV is comparable to that from CMV IE promoter, the degree of regulation from pSiaIV is predominantly dependent on the leakiness of tRP in a given cell line. The maximal efficiency of pSiaIV may not have been demonstrated in these experi- longer duration of pSiaIV expression could be followed.
plates in culture medium containing no Dox or this antibiotic at final
The positive feedback bidirectional promoter system tTA transcription. With the conventional system, Tc abolishes the activity of the tTA, but its production continues driven from the CMV IE promoter. At steady level, an Discussion equilibrium may be reached between the production of tTA and its inactivation by Tc, whereby some active tTA The general use of the Tc-regulatable system for gene therapy depends on the delivery of both the tTA and the may remain in the cell. (2) Attempts to obtain stable tTAexpressing clones have been unsuccessful in certain cell tRP on a single vector. Here, we describe the construction and analysis of several suitable self-contained vectors.
types, 38 suggesting possible cytotoxicity of tTA in high concentrations. It has been suggested that high-level The constructs were tested in transient transfections as a model for nonintegrating gene delivery systems and their expression of VP16 in animal cells inhibits normal transcription by RNA polymerase II and thus results in arrest functionality was further confirmed in stable transfectants. As a reporter gene, mGM-CSF, a cytotoxic protein of cell growth 34 by sequestering transcription factors in a nonproductive initiation complex. 33 Having the proin excess 3,4 with potential application for gene therapy 1,2,4,35 was used. The lack of regulation of pSiaII in our duction of tTA controlled effectively may thus be advantageous in those cells sensitive to high concentrations of initial studies is mainly due to the high basal activity of its Tc-repressed tRP, presumably due to the presence of tTA. Moreover, using this system, establishment of cell lines expressing tTA and a toxic gene should become enhancer elements on the plasmid. Wasylyk et al 36 have in fact shown that for the SV40 promoter, the transcripmore feasible due to the inactivation of tTA and increased repression of both tTA and the toxic gene tional activity of the promoter is 10-fold lower in enhancerless constructs. To address this issue, we characexpression in response to Tc. (3) As with other single plasmids, the approach prevents segregation of the terised a bidirectional promoter totally lacking enhancer elements and employed it in the construction of a PFRS. expression and regulation units, ensuring equal copy number of these units at the same chromosomal locus. The bidirectional promoter expresses mIL-2 and mGM-CSF, with the same efficiency as the corresponding parThis avoids unbalanced copy numbers, which may result in poor regulation due to excess background reporter ental vectors. Also, the repression of the bidirectional promoter in response to Tc treatment is comparable for gene or limited tTA supply. (4) The PFRS shows enhanced sensitivity to Dox in comparison to the doseboth genes and with those of the parental vectors. This indicates that quantitative regulation from the bidirecresponse studies of Dox in 293-pSiaII. 32 The enhanced sensitivity of the PFRS to Dox is not only exhibited by tional promoter is comparable for the two genes. Obviously, this control could either be down-regulation or upits repressibility at lower Dox concentrations but also by a more prolonged delay in resumption of tRP activity. regulation in the presence of Tc depending on the use of tTA or rtTA, 37 respectively. Following the removal of 1000 ng/ml of Dox from AM12-pSiaIV cells, the system takes over 9 days to reach about Having demonstrated that tRP of the bidirectional system can function efficiently and comparably in either 30% of its maximal expression (data not shown). This is in contrast to our observation on integrated pSiaII in 293 direction, a regulatable, positive feedback system on the basis of the bidirectional promoter was constructed.
cells (293-pSiaII) which reaches its maximal expression within 9 days. 32 Despite a reasonable level of regulation, the plasmid exhibited a low level of reporter gene expression. To Recently, several single plasmids have been constructed and delivered to cells directly or via recombinant improve both the expression of the gene and its regulation, the bidirectional promoter was redesigned to viruses. In contrast to our results, similar constructs to 47 Large-scale plasmid prepvector, expressing a reporter gene from a tRP followed arations were carried out by anion exchange chromatoby tTA expression from a CAP-independent translational graphy (Qiagen, Surrey, UK), according to the enhancer sequence distal to the reporter gene. They manufacturer's protcol. All the restriction endonucleases reported a 40-fold regulation of gene expression in mice were purchased from New England Biolabs 7 days after intramuscular injection of a bicistronic vec-(Hertfordshire, UK). tor. A similar bicistronic construct on a retrovirus demonComplementary DNA was prepared from conconavastrated one or two orders of magnitude gene regulation lin A-stimulated 48 spleen cells of a Balb/c mouse using after two rounds of enrichment by FACS sorting for cells a standard method. 49 The mouse GM-CSF and mouse expressing high reporter gene activity. 26 Compared to the interleukin-2 (mIL-2) cDNAs were generated by the polybicistronic vectors, the level of regulation from pSiaIV is merase chain reaction and were subsequently verified by higher in both transient and stable forms. In fact, the level sequencing (USB, Ohio, USA). of control achieved with pSiaIV is the highest regulation
The plasmid pUHD 15-1 contains the tTA transactivthat has been reported from a single construct in transient ator gene and pUHD 10-3 carries a tRP followed by a studies. Furthermore, pSiaIV in the integrated form dispolylinker. 11 The 530 bp XbaI/BamHI mIL-2 cDNA and plays a similar or superior degree of gene regulation to the 462 bp XbaI/BamHI mGM-CSF cDNA were inserted most of the approaches mentioned above despite using into the XbaI site of pUHD 10-3 to construct pCMV* −1 pooled stable cells rather than selected clones. mIL-2 and pCMV* −1 mGM-CSF, respectively. pCMV Unlike bicistronic vectors, it is possible to selectively mGM-CSF was constructed by cloning the NheI-BamHI enhance the expression of tTA in positive feedback regufragment of pCMV* −1 mGM-CSF, containing mGM-CSF, latory vectors without compromising the expression of into the EcoRI-BamHI site of pUHD 15-1. To construct the reporter gene. Our data suggest that, by modifying pCEP4.tTA, the hygromycin expression cassette together the intrinsic properties of a bidirectional promoter, it is with the chloramphenicol resistance gene, OriP and the feasible to obtain different levels of expression from each EBNA1 gene of pCEP4.Cm R were digested by ClaI-NruI half of the promoter. Excising the sequence between the and inserted into the XhoI site of pUHD 15-1. pCEP4.Cm R tet operators and the TATA box of the mGM-CSF-half of is an EBV-based vector whereby the CMV promoter and the bidirectional promoter decreases the level of basal SV40 poly(A) sequences of parental pCEP4 are replaced and maximal expression of mGM-CSF by five-fold relawith the chloramphenicol resistance gene from tive to the unmodified bidirectional promoter (data not pACYC184 (New England Biolabs). For construction of shown). Also as our data indicate, inclusion of a CCAAT pSiaII, the 1 kb EcoRI-BamHI tTA coding sequence of box upstream of tTA had little or no effect on the basal pUHD 15-1 was subcloned into pCI.neo (plasmid conexpression of mGM-CSF from the other half of the biditaining chimeric intron; Promega, Southampton, UK) at NotI-EcoRI site to construct pCI.tTA.neo. The 1.35 kb rectional promoter. Expression and regulation from PvuII-SspI mGM-CSF expression cassette of pCMV* −1 pSiaIV could potentially be further enhanced by inclusion mGM-CSF was then cloned at the BamHI site of of a suitable transcription factor binding site 40 or a terpCI.tTA.neo in the opposite direction to the tTA and neominal deoxynucleotidyl transferase initiator element 41 mycin phosphotransferase expression cassettes (being in within the tTA-half of the promoter, by including a sense). To construct, pCMV* −1 mGM-CSF/mIL-2, the nuclear localisation signal within tTA, and/or by using PvuII-SmaI mIL-2 expression cassette of pCMV* −1 mIL-2 an alternative poly (A) sequence.
was inserted at the XhoI site of pCMV* −1 mGM-CSF in the The PFRS could prove to be a powerful approach for opposite direction to the mGM-CSF expression. The targeting specific tissues or cells. A number of cis-acting upstream regions of the mIL-2 and the mGM-CSF genes, control sequences conferring tissue specificity have been up to −33 bp from the TATA box, are therefore separated identified. [42] [43] [44] [45] [46] By inclusion of a cis-acting control by seven copies of the tet operator. For construction of sequence on the tTA-half of the promoter, it is possible pCMV* −1 tTA/mGM-CSF, the EcoRI-BamHI tTA sequence to regulate expression of tTA in a tissue-specific manner.
of pUHD 15-1 was subcloned into pUHD 10-3 at EcoRITissue-specific expression can be further restricted by BamHI site to construct pCMV* tTA, containing the tTA exother half of the bidirectional promoter. pression cassette, was cloned at the XhoI site of In conclusion, we show that it is possible to modify the pCMV* −1 mGM-CSF in the opposite direction to the intrinsic properties of a bidirectional promoter so as to mGM-CSF expression. The plasmid pCI* −1 tTA/mGMconstruct a novel single Tc-contolled positive feedback CSF was constructed by removing the tTA expression regulatory vector with a high expression upon induction cassette from pCI.tTA.neo with SgfI-DraIII. This fragment and low basal expression upon repression. This vector includes the CCAAT and TATA boxes of the CMV IE transcribes a reporter gene as efficiently as the intact promoter, the chimeric intron, the tTA sequence and the CMV IE promoter and is repressed to the leakiness of the SV40 poly (A). It was cloned into the XhoI site of pCMV* tRP in response to Tc. The system functions well in an −1 mGM-CSF in the opposite direction to the mGM-CSF intra-and extra-chromosomal form and could be applied expression. To construct pSiaIV, the oligonucleotides in many gene therapy applications.
5′ TCGAGGCGGCCGCACCATGT 3′ and 5′ CTAGAC-ATGGTGCGGCCGCC 3′ (translational initiation codon underlined) 50 were annealed and ligated at the XhoI-XbaI site to replace the translational initiation sequence of tTA. 
